Author:
Delyon Julie,Lebbe Celeste
Reference10 articles.
1. Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses;Betts;Blood,2011
2. Colon immune-related adverse events: anti-CTLA-4 and anti-PD-1 blockade Induce distinct Immunopathological Entities;Coutzac;J. Crohns Colitis,2017
3. Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients;Gérard;J. Immunother. Cancer,2021
4. Interleukin-6 Blockade Abrogates Immunotherapy Toxicity and Promotes Tumor Immunity;Hailemichael,2022
5. Targeting the IL-6/JAK/STAT3 signalling axis in cancer;Johnson;Nat. Rev. Clin. Oncol.,2018
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献